ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

First analysis From Profiles Reveal New Data On Centers

November 18, 1977

Group Chairs Respond to Center Directors’ White Paper

April 1, 2011

In Brief: Henney Permanent NCI Deputy Director; 17 Regional Cooperative Group Applications Get First Review

February 5, 1982

NIH News: Varmus Presents “Modest Proposal for a Simpler NIH”

August 6, 1999

FDA Invites Ad Hoc Consumer Reps To ODAC Meetings

February 17, 1995

NCI Clinical Research Too Similar To Work By Extramural Community, Report Finds

July 21, 1995